Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism

被引:92
作者
Huang, Jiangeng [1 ]
Si, Luqin [1 ]
Jiang, Lingli [1 ]
Fan, Zhaoze [1 ]
Qiu, Jun [1 ]
Li, Gao [1 ]
机构
[1] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Dept Pharmaceut, Wuhan 430030, Peoples R China
基金
中国国家自然科学基金;
关键词
P-glycoprotein; pluronic F68 block copolymer; CYP3A4; Caco-2; everted gut sac;
D O I
10.1016/j.ijpharm.2007.12.028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to investigate the effects of pluronic F68 block copolymer on the P-gp-mediated transport of celiprolol (CEL) and CYP3A4-mediated formation of midazolam (MDZ) metabolite 1'-hydroxymidazolam. Over a range from 0.03 to 0.3%, pluronic F68 increased apical-to-basolateral permeability (AP-BL) and decreased basolateral-to-apical permeability (BL-AP) of the P-gp substrate CEL in Caco-2 cell monolayer with the efflux ratio values of 2.8 +/- 0.3 (0.03%), 2.6 +/- 0.3 (0.1%), 2.3 +/- 0.2 (0.3%), respectively. CEL transport across the intestinal mucosa in the everted gut sac model was also enhanced by the P-gp inhibitor verapamil and the pharmaceutical excipient pluronic F68. Furthermore, CYP3A4-catalyzed formation of 1'-hydroxymidazolam was inhibited by pluronic F68 with IC50 and K-i values of 0.11 and 0.16 mg/ml, respectively. The results indicate that pluronic F68 is a potent in vitro inhibitor of both P-gp and CYP3A4, suggesting a potential for pluronic F68 to modify the pharmacokinetics of orally administered drugs that are P-gp and/or CYP3A4 substrates in vivo. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:351 / 353
页数:3
相关论文
共 8 条
[1]   The improved everted gut sac: a simple method to study intestinal P-glycoprotein [J].
Barthe, L ;
Bessouet, M ;
Woodley, JF ;
Houin, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 173 (1-2) :255-258
[2]   Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo [J].
Cornaire, G ;
Woodley, J ;
Hermann, P ;
Cloarec, A ;
Arellano, U ;
Houin, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 278 (01) :119-131
[3]   In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam [J].
González, RCB ;
Huwyler, J ;
Boess, F ;
Walter, I ;
Bittner, B .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2004, 25 (01) :37-49
[4]   Pluronic® block copolymers for overcoming drug resistance in cancer [J].
Kabanov, AV ;
Batrakova, EV ;
Alakhov, VY .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :759-779
[5]   Effect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestines [J].
Lo, YL ;
Liu, FI ;
Cherng, JY .
JOURNAL OF CONTROLLED RELEASE, 2001, 76 (1-2) :1-10
[6]   Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450 [J].
Mountfield, RJ ;
Senepin, S ;
Schleimer, M ;
Walter, I ;
Bittner, B .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 211 (1-2) :89-92
[7]   Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug [J].
Toyobuku, H ;
Tamai, I ;
Ueno, K ;
Tsuji, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (11) :2249-2259
[8]   Validated assays for human cytochrome P450 activities [J].
Walsky, RL ;
Obach, RS .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (06) :647-660